Fund moves
7.7%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 4, 2026 · Filed Nov 6, 2026
A Promis Neurosciences director paid $91K out of pocket for Promis Neurosciences shares. 1 other person at Promis Neurosciences bought some too, in the same month. Shares held went up 193% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$90,895
Shares × reported transaction price
$25K–$100K
+193.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 5 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
83 days after results of Aug 13, 2026, 8 days before results of Nov 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $3.52 on Nov 4, 2026, 17% above its 52-week low and 86% below its high, after a 73% drop over the previous 30 trading days
52-week range $3.00 (Nov 2, 2026) to $24.79 (Mar 5, 2026), 2% of the way up, from 251 adjusted closes. 30 trading days earlier: $12.94 on Sep 23, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 8 days before PMN reported its results (Nov 12, 2026). Eugene Williams's largest purchase of PMN in their filings since 2022
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Insider buying
10 days before resultsTraded Nov 2 · filed 1 day later
A Promis Neurosciences director paid $39K out of pocket for Promis Neurosciences shares. 1 other person at Promis Neurosciences bought some too, in the same month. It was the first purchase in 21 months.
Insider buying
13 days before resultsTraded Oct 30 · filed 4 days later
A Promis Neurosciences director paid $5.3K out of pocket for Promis Neurosciences shares. 1 other person at Promis Neurosciences bought some too, in the same month. It was the first purchase in 7 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.